PDGFRB and systemic sclerosis: However, the study did not confirm whether these histological changes were specifically induced by anti-AT1R or anti-ETAR antibodies, since it could be due to other agnostic autoantibodies, such as anti-platelet-derived growth factor receptor (anti-PDGFR) antibodies that can be co-present in SSc patient sera.